FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Power Metals entered into a cesium concentrate offtake agreement with Albemarle Corporation, a US$16 billion global critical ...
ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with ...
Solutions Market Overview:The global electronic clinical outcome assessment (eCOA) solutions market is expected to grow at a ...
The global breast biopsy devices market is projected to experience a compound annual growth rate (CAGR) of approximately 6% ...
The global medical humidifier market is projected to experience a growth rate of approximately 6% over the next five years.
The Phase 3 STAR-221 study evaluating a domvanalimab-based combination in upper gastrointestinal cancers will be discontinued due to futilityArcus is continuing to expand its development program for ...
The "Peptide Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The global peptide cancer vaccine market is expected ...
LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight management has undergone a seismic shift. Zealthy is one of the fastest-growing telehealth weight-loss platforms in the ...
Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.The global expanded PTFE market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The ...
ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback